Charles River Laboratories (Massachusetts) Announces Fourth-Quarter And Full-Year 2013 Results From Continuing Operations And Provides 2014 Guidance
2/12/2014 8:21:43 AM
WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) today reported its results for the fourth-quarter and full-year 2013 and provided guidance for 2014. For the quarter, net sales from continuing operations were $289.2 million, an increase of 3.2% from $280.1 million in the fourth quarter of 2012. Foreign currency translation reduced sales by 0.5%. Sales growth was driven primarily by the Preclinical Services (PCS) segment.
Help employers find you! Check out all the jobs and post your resume.
comments powered by